In an interview with top Italian newspaper Il Sole 24 Ore Stefano Casola, director of the IFOM research unit Genetics of B Cells and Lymphomas, explains the close collaboration with Tasuku Honjo, the Japanese scientist who will be awarded the 2018 Nobel Prize for Medicine and anticipates the Joint Research lab that IFOM will launch in 2019 with the Kyoto University Medical School. The IFOM-Kyoto Joint Research Lab will be focussed on the molecular mechanisms underlying cancer immunology, a new challenging partnership besides those launched by IFOM since 2012 with prestigious research institutions in Singapore, India and Cina.

The interview Il premio Nobel per la medicina in partnership con la ricerca italiana